[go: up one dir, main page]

MX370055B - Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer. - Google Patents

Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer.

Info

Publication number
MX370055B
MX370055B MX2015014713A MX2015014713A MX370055B MX 370055 B MX370055 B MX 370055B MX 2015014713 A MX2015014713 A MX 2015014713A MX 2015014713 A MX2015014713 A MX 2015014713A MX 370055 B MX370055 B MX 370055B
Authority
MX
Mexico
Prior art keywords
treatment
juice
cancer
composition
fish oil
Prior art date
Application number
MX2015014713A
Other languages
English (en)
Other versions
MX2015014713A (es
Inventor
Sande Mathisen Janne
Original Assignee
Smartfish As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50792503&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX370055(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smartfish As filed Critical Smartfish As
Publication of MX2015014713A publication Critical patent/MX2015014713A/es
Publication of MX370055B publication Critical patent/MX370055B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se refiere a una composición que comprende una combinación de aceite de pescado y jugo en una emulsión de aceite en agua, para usarse en el tratamiento y/o postratamiento de cáncer, en donde dicho aceite de pescado se selecciona de aceite de pescado que tiene valor Totox debajo de 20 y un contenido de omega-3 superior al 10% en peso con base en el peso total del aceite de pescado y en donde se utiliza una emulsionante adecuado pata estabilizar la emulsión, en donde los tipos de cáncer tratados se seleccionan entre el grupo que consiste en cáncer pancreático, cáncer colorrectal, cáncer neurológico, cáncer de mama, cáncer de próstata, cáncer de pulmón y cáncer de piel, y dicho postratamiento de cáncer comprende el tratamiento de la caquexia, la deficiencia de vitamina D, fatiga, o la estimulación del sistema inmunitario.
MX2015014713A 2013-04-22 2014-04-22 Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer. MX370055B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20130552 2013-04-22
PCT/NO2014/050061 WO2014175748A1 (en) 2013-04-22 2014-04-22 Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer

Publications (2)

Publication Number Publication Date
MX2015014713A MX2015014713A (es) 2016-06-06
MX370055B true MX370055B (es) 2019-11-29

Family

ID=50792503

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015014713A MX370055B (es) 2013-04-22 2014-04-22 Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer.

Country Status (18)

Country Link
US (2) US9877944B2 (es)
EP (1) EP2991507B1 (es)
JP (1) JP6495245B2 (es)
KR (1) KR102253929B1 (es)
CN (1) CN105120683A (es)
AU (1) AU2014258007B2 (es)
BR (1) BR112015025787B1 (es)
CA (1) CA2909409A1 (es)
DK (1) DK2991507T3 (es)
ES (1) ES2753387T3 (es)
HR (1) HRP20191912T1 (es)
HU (1) HUE046885T2 (es)
LT (1) LT2991507T (es)
MX (1) MX370055B (es)
PL (1) PL2991507T3 (es)
PT (1) PT2991507T (es)
SI (1) SI2991507T1 (es)
WO (1) WO2014175748A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014258007B2 (en) 2013-04-22 2019-01-17 Smartfish As Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer
WO2016168021A1 (en) * 2015-04-14 2016-10-20 Atossa Genetics, Inc. Compositions and methods of treatment of breast disorders and estrogen-related disorders
NO20160913A1 (en) * 2016-05-27 2017-11-28 Smartfish As Use of a composition comprising marine oil and juice for improving muscle performance.
JP7123945B2 (ja) 2016-10-03 2022-08-23 シャー，ホウン・サイモン がん放射線療法を増強するための組成物および方法
JP7336994B2 (ja) 2017-06-13 2023-09-01 シャー，ホウン・サイモン 温熱療法治療を増強するための組成物および方法
CN111479577A (zh) 2017-06-13 2020-07-31 夏滉 用于增强癌症放疗的组合物和方法
EP3638247A4 (en) 2017-06-13 2021-03-03 Houn Simon Hsia COMPOSITIONS AND PROCEDURES FOR IMPROVING CHEMOTHERAPY AGAINST CANCER
CN108208838A (zh) * 2018-03-09 2018-06-29 北京素维生物科技有限公司 一种掩味组合物及其用途
WO2020225217A1 (en) * 2019-05-07 2020-11-12 Lynxit Sport Nutrition As Omega-3 beverage
CN113413532B (zh) * 2021-07-01 2022-03-01 曾迎春 基于虚拟现实的癌症相关认知障碍评估与康复训练系统
CN115317543B (zh) * 2022-09-13 2023-05-23 复旦大学附属金山医院(上海市金山区眼病防治所、上海市金山区核化伤害应急救治中心) 一种治疗肝癌恶病质的中药组合物及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0175468A3 (en) * 1984-08-10 1987-07-22 Sentrachem Limited Eicosanoids for use in cancer therapy
GB9423625D0 (en) 1994-11-23 1995-01-11 Scotia Holdings Plc Fortified fruit juice
CA2260397A1 (en) * 1999-01-29 2000-07-29 Atlantis Marine Inc. Method of converting rendered triglyceride oil from marine sources into bland, stable food oil
JP2000281572A (ja) * 1999-03-30 2000-10-10 Bizen Kasei Kk 殺癌細胞剤及びこれを配合してなる組成物
US20020012710A1 (en) 1999-11-29 2002-01-31 Rimonest Ltd. Pomegranate products useful in improving health and methods of use thereof
US20020188024A1 (en) 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
NO317310B1 (no) * 2003-02-28 2004-10-04 Bioli Innovation As Olje-i-vann emulsjonskonsentrat for ernaeringsformal, samt anvendelse derav.
GB0503684D0 (en) * 2005-02-23 2005-03-30 Ici Plc Emulsifiers and emulsions
ES2264886B1 (es) 2005-05-12 2008-02-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.
CN100418427C (zh) * 2005-09-13 2008-09-17 仙桃市泰尔生物科技开发有限公司 保健型鱼奶加工方法
US20090202679A1 (en) * 2005-11-29 2009-08-13 Pharmalogica As Composition comprising fish oil and juices
NO20081487L (no) 2008-03-27 2009-09-28 Smartfish As Helsefremmende drikk
JP5872453B2 (ja) * 2009-04-17 2016-03-01 ナタク ファルマ エセ．エレ． フィタン酸含量が低く、ω−３脂肪酸に富む組成物
AU2014258007B2 (en) 2013-04-22 2019-01-17 Smartfish As Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer

Also Published As

Publication number Publication date
EP2991507B1 (en) 2019-08-07
MX2015014713A (es) 2016-06-06
BR112015025787A8 (pt) 2019-12-24
KR20160008200A (ko) 2016-01-21
HUE046885T2 (hu) 2020-03-30
PT2991507T (pt) 2019-11-12
BR112015025787B1 (pt) 2021-01-12
US20180110749A1 (en) 2018-04-26
PL2991507T3 (pl) 2020-02-28
CN105120683A (zh) 2015-12-02
AU2014258007A1 (en) 2015-10-15
SI2991507T1 (sl) 2020-02-28
AU2014258007B2 (en) 2019-01-17
LT2991507T (lt) 2019-12-10
DK2991507T3 (da) 2019-11-04
CA2909409A1 (en) 2014-10-30
HK1221874A1 (en) 2017-06-16
HRP20191912T1 (hr) 2020-01-10
ES2753387T3 (es) 2020-04-08
WO2014175748A1 (en) 2014-10-30
KR102253929B1 (ko) 2021-05-20
US9877944B2 (en) 2018-01-30
US20160067202A1 (en) 2016-03-10
BR112015025787A2 (pt) 2017-07-25
EP2991507A1 (en) 2016-03-09
JP2016517865A (ja) 2016-06-20
JP6495245B2 (ja) 2019-04-03
US10188622B2 (en) 2019-01-29

Similar Documents

Publication Publication Date Title
MX2015014713A (es) Uso de una composicion que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cancer.
MX2015011899A (es) Metodos para el tratamiento de cáncer y prevención de resistencia a los fármacos para el cáncer.
MX2015011606A (es) Metodo para tratar cancer y prevenir resistencia a farmacos contra cancer.
EP3504305A4 (en) METHOD FOR TREATING SALT WATER FROM OIL AND GAS HOLES
EP3015114C0 (en) OIL-IN-WATER EMULSION NOT CONTAINING SURFACTANT, AND ITS USE
MX2016015181A (es) Combinacion de un anticuerpo del receptor 4 de quimiocina anti-cc y un agonista de 4-1 bb para el tratamiento del cancer.
EA201992251A1 (ru) Противораковые вакцины и способы лечения с их применением
EA201590997A1 (ru) Соединения и способы их применения
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
IL276733A (en) Use of Aribolin in cancer treatment
IL266636B (en) Biologically stable cannabinoids and a method for increasing their physiological concentration
PH12015502469A1 (en) Fcrn-binding abolished anti-igf-ir antibodies and their use in the treatment of vascular eye diseases
AU363477S (en) Insect barrier device
AU350280S (en) Apparatus for skin treatment
EA201691108A1 (ru) Хиназолин-thf-амины в качестве ингибиторов pde1
PH12016501838A1 (en) Compounds and their methods of use
AU358921S (en) Blood processing device
MX2015013378A (es) Uso de sedoheptulosa para la prevencion y tratamiento de inflamacion.
AU2014353885A8 (en) Prevention and treatment of toxicosis
PH12015500468B1 (en) Treatment and prevention of acne
AU355724S (en) Tensioner bracket
TH1501006717B (th) องค์ประกอบอิมัลชั่นชนิดน้ำมัน-ใน-น้ำและวิธีการปรับสภาพพื้นผิวโดยใช้สิ่งนั้น
UA115417U (xx) Спосіб профілактики та лікування гіпоксичних змін при карбоперитонеумі
TH1401007142A (th) ยาสำหรับป้องกันและ/หรือรักษาโรคถุงน้ำในไต
TH1501005802A (th) องค์ประกอบกาแลคโตโอลิโกแซคคาไรด์สำหรับใช้ในการป้องกัน หรือรักษาความผิดปกติในการรับรู้และความผันแปรทางอารมณ์ในการเจ็บป่วย ทางจิตประสาทหรือความชรา

Legal Events

Date Code Title Description
FG Grant or registration